ArthNow Logo
ArthNow
•3 min read•
✦Reported by Reuters

US signed off on sales of nearly 900,000 AI chips to China in six months, House committee says

US signed off on sales of nearly 900,000 AI chips to China in six months, House committee says
Source: Reuters

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓The US approved sales of nearly 900,000 AI chips to China over six months, a House committee said.
  • ✓Companies sought permission to ship over 3.4 million chips during this period.
  • ✓Chris McGuire said, "The fact that over 30% of the AI chips sent to China were shipped to companies is astonishing."

Story at a Glance

Category
Indian Markets
Reported By
Reuters
Reading Speed
3 Minute(s)
Market Focus
India Economy

Sign up here.

The unusual ​release of chip export licensing data comes as the administration of President Donald Trump faces heightened scrutiny following news about former Nvidia ​CEO Jensen Huang’s affair with an alleged Chinese spy, which has fueled renewed calls in Washington for a tougher ⁠stance on China.

Companies had sought permission to ship over 3.4 million chips to China during the period, the documents showed. It was not ​immediately clear how many of the approvals resulted in actual China-bound shipments of chips, which included Nvidia's H200 and AMD's equivalent MI325X.

News surrounding ​Huang has turned a spotlight on instances of Nvidia AI chips being smuggled to China that went unpunished, dialing up pressure on the Trump administration to crack down on Chinese tech threats.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Reuters

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.